• METTL16-SENP3-LTF Axis Drives Ferroptosis Resistance in HCC

  2026-07-17

  Wang et al. identify the METTL16-SENP3-LTF signaling axis as a key regulator of ferroptosis resistance and tumorigenesis in hepatocellular carcinoma (HCC). Their mechanistic insights highlight new possibilities for targeting iron metabolism and cell death pathways in liver cancer.

• Refining In Vitro Drug Response Metrics in Cancer Research

  2026-07-17

  Schwartz (2022) introduces a methodological advance for evaluating anti-cancer drug responses in vitro by rigorously distinguishing between proliferative arrest and cell death. This nuanced approach offers researchers greater precision in assessing agents such as survivin inhibitors, potentially improving the translational relevance of preclinical data.

• Sulfisomidine: Advanced Biochemical Tool for Enzyme and Meta

  2026-07-16

  Explore the multifaceted scientific utility of Sulfisomidine in enzyme kinetics, microbial metabolism, and oxidative stress regulation. This in-depth review unveils novel insights and protocol guidance, setting it apart from standard application guides.

• Tofacitinib citrate (CP-690550 citrate): Reliable JAK3 Inhib

  2026-07-16

  This article provides scenario-driven guidance for cell-based immune regulation research using Tofacitinib citrate (CP-690550 citrate), SKU A4135. It addresses real laboratory challenges with data-backed solutions, emphasizing reproducibility, selectivity, and workflow compatibility. Explore how validated use of this selective JAK3 inhibitor, supplied by APExBIO, can support robust and interpretable cell viability, proliferation, and cytotoxicity assays.

• Carbenoxolone disodium: Technical Guide for 11β-HSD Inhibiti

  2026-07-15

  Carbenoxolone disodium is a high-purity 11β-hydroxysteroid dehydrogenase inhibitor designed for tissue- and cell-based research on glucocorticoid regulation, corticosterone metabolism, and gap junction communication. It is not recommended for in vivo efficacy studies or experiments where precise off-target control is required.

• Regorafenib Targets RRM2 to Suppress Melanoma Progression

  2026-07-15

  A recent iScience study reveals that Regorafenib (BAY 73-4506) inhibits melanoma progression by downregulating RRM2 through ERK/E2F3 signaling, leading to reduced tumor growth and metastasis. These findings clarify a novel mechanistic axis underlying Regorafenib’s anti-melanoma effects and provide actionable direction for translational cancer biology and angiogenesis research.

• Enhanced Lysosomal Exocytosis Drives Cartilage Pathology in

  2026-07-14

  This study uncovers how enhanced lysosomal exocytosis, rather than just substrate accumulation, contributes to cartilage pathology in mucopolysaccharidosis type IVA (MPS IVA) by disrupting growth factor signaling. The findings shift the mechanistic understanding of lysosomal storage disorders and inform new experimental strategies for skeletal disease research.

• TBST (Tris-Buffered Saline and Tween 20): Scientific Foundat

  2026-07-14

  Discover the scientific underpinnings of TBST (Tris-Buffered Saline and Tween 20) and its pivotal role in antibody-based assays, with a unique focus on metastasis research and decision-making for high-fidelity immunoassays. This article offers a distinct, in-depth perspective not found in existing guides.

• Epinephrine Bitartrate: Redefining Adrenergic Signaling for

  2026-07-13

  This thought-leadership article explores the mechanistic and strategic landscape of (-)-Epinephrine (+)-bitartrate, a non-selective adrenergic receptor agonist, in translational research. Bridging robust experimental evidence with actionable guidance, it highlights the compound’s unique value for cardiovascular, neurobiology, and sympathetic nervous system studies while critically evaluating administration strategies, protocol parameters, and translational relevance. Insights are grounded in peer-reviewed data and cross-referenced with leading content assets to provide an advanced discussion beyond standard product pages.

• Cyanidin Chloride: Anthocyanin Polyphenolic Antioxidant in C

  2026-07-13

  Cyanidin Chloride is a high-purity anthocyanin polyphenolic antioxidant with demonstrated efficacy in oxidative stress research and cellular protection models. It inhibits inflammatory cytokine expression and restores skin barrier function, supporting its role in psoriasis and cell-based antioxidant studies.

• ATS-9R: Advanced Gene Silencing in Adipocytes for Metabolic

  2026-07-12

  ATS-9R (Adipocyte-targeting sequence-9-arginine) from APExBIO empowers highly specific, non-viral gene delivery to white adipose tissue, revolutionizing research on obesity, insulin resistance, and adipocyte biology. This guide details experimental workflows, troubleshooting, and best practices for leveraging ATS-9R's prohibitin-mediated targeting efficiency.

• Protein A/G Magnetic Beads: Practical Guidance for Purificat

  2026-07-10

  Protein A/G Magnetic Beads (SKU K1305) address the need for efficient, low-background antibody purification and protein-protein interaction analysis from complex biological samples. They are ideal for immunoprecipitation, co-immunoprecipitation, and chromatin immunoprecipitation workflows, but are not intended for diagnostic or medical use.

• A40926 (SKU BA1486): Reliable Glycopeptide for Antibacterial

  2026-07-09

  This article examines practical laboratory scenarios where A40926 (SKU BA1486) provides reproducible, sensitive solutions for Gram-positive and multidrug-resistant bacterial research. Through scenario-driven Q&A, we highlight how APExBIO’s A40926 supports robust in vitro antibacterial assays and MRSA studies, emphasizing validated MICs, workflow compatibility, and supplier reliability.

• PDHA1 Succinylation Drives α-Ketoglutarate–Mediated Immune E

  2026-07-09

  This study identifies PDHA1 succinylation at lysine 83 as a critical driver of α-ketoglutarate accumulation in cholangiocarcinoma, which suppresses macrophage antigen presentation and promotes immune evasion via OXGR1-MAPK signaling. Targeting PDHA1 succinylation emerges as a promising strategy to overcome chemotherapy resistance and improve treatment outcomes.

• Enhanced Production of A40926 via Engineered Nonomuraea Stra

  2026-07-08

  This study presents a combined genetic and media optimization strategy that significantly increases the fermentation yield of A40926, a key dalbavancin precursor, in Nonomuraea gerenzanensis. The findings offer actionable insights for improving glycopeptide antibiotic production for Gram-positive bacterial infection research.

451 records 11/31 page Previous Next First page 上5页 1112131415 下5页 Last page